dalteparin has been researched along with Pleural Effusion in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Pleural Effusion: Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhadad, A | 1 |
| Acosta, S | 1 |
| Sarabi, L | 1 |
| Kölbel, T | 1 |
1 other study available for dalteparin and Pleural Effusion
| Article | Year |
|---|---|
Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids.
Topics: Anticoagulants; Blood Coagulation Factors; Dalteparin; Doping in Sports; Enoxaparin; Hematoma, Subdu | 2010 |